Amanta Healthcare IPO Set to Open with Promising Grey Market Premium
Amanta Healthcare Ltd., a specialized pharmaceutical company, is launching its IPO on September 1. The mainboard issue aims to raise Rs 126 crore by offering one crore fresh shares priced between Rs 120-126. The grey market shows a premium of Rs 22 per share, indicating potential listing gains of 17.46%. The company specializes in sterile liquid pharmaceuticals and has seen a significant increase in net profit from Rs 3.63 crore to Rs 10.50 crore, despite a slight decrease in total income. IPO proceeds will fund new manufacturing lines at the Hariyala facility. The IPO closes on September 3, with listing expected on September 9 on BSE and NSE.
*this image is generated using AI for illustrative purposes only.
Amanta Healthcare Ltd., a specialized pharmaceutical company, is gearing up for its Initial Public Offering (IPO) set to launch on September 1. The mainboard issue, priced in the range of Rs 120-126 per share, aims to raise Rs 126.00 crore through the issuance of one crore fresh shares.
Grey Market Indicates Potential Listing Gains
The grey market is showing a positive sentiment towards Amanta Healthcare's IPO, with a premium of Rs 22.00 per share. This suggests an estimated listing price of Rs 148.00, potentially offering gains of 17.46% to investors upon listing.
Company Profile and Performance
Amanta Healthcare specializes in developing sterile liquid pharmaceutical products using advanced technologies. The company's product portfolio includes over 45 generic products, which are distributed through a network of 320 distributors. Additionally, the company has established its presence in international markets through exports to multiple regions.
Financial Highlights
While the company's total income saw a slight decrease from Rs 281.61 crore to Rs 276.09 crore, its profitability showed significant improvement:
| Financial Metric | Previous Period | Recent Period |
|---|---|---|
| Total Income | Rs 281.61 crore | Rs 276.09 crore |
| Net Profit | Rs 3.63 crore | Rs 10.50 crore |
The substantial increase in net profit, despite a marginal decrease in total income, indicates improved operational efficiency and cost management.
IPO Proceeds Utilization
The funds raised through the IPO will be primarily used to finance new manufacturing lines at the company's Hariyala facility. This expansion is likely aimed at enhancing production capabilities and potentially broadening the product range.
Key Dates for Investors
- IPO Opening Date: September 1, 2023
- IPO Closing Date: September 3, 2023
- Expected Listing Date: September 9, 2023
- Listing Venues: BSE and NSE
Investors interested in participating in the Amanta Healthcare IPO should note these dates and conduct thorough research before making any investment decisions. As always, it's advisable to review the company's prospectus and consult with financial advisors to assess the suitability of this investment opportunity in line with individual financial goals and risk tolerance.
16
